title: Optimizing chronic transfusion therapy for survivors of hemoglobin Barts hydrops fetalis.
authors.affiliation: Division of Haematology/Oncology, Department of Paediatrics.
authors.forename: Ali
authors.identifier: http://orcid.org/0000-0001-6926-7502
authors.initials: A
authors.lastname: Amid
authors.affiliation: Department of Biostatistics, and.
authors.forename: Shiyi
authors.initials: S
authors.lastname: Chen
authors.affiliation: Department of Laboratory Medicine and Pathobiology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
authors.forename: William
authors.initials: W
authors.lastname: Brien
authors.affiliation: Division of Haematology/Oncology, Department of Paediatrics.
authors.forename: Melanie
authors.initials: M
authors.lastname: Kirby-Allen
authors.affiliation: Division of Haematology/Oncology, Department of Paediatrics.
authors.forename: Isaac
authors.identifier: http://orcid.org/0000-0002-9008-6236
authors.initials: I
authors.lastname: Odame
mesh_terms: D000293:Adolescent; D001803:Blood Transfusion / Q000379:methods*; D002648:Child; D004920:Erythropoiesis; D005260:Female; D006455:Hemoglobins, Abnormal / Q000378:metabolism*; D006720:Homozygote; D006801:Humans; D015160:Hydrops Fetalis / Q000628:therapy*; D008297:Male; D017741:Survivors
chemical_list: D006455:Hemoglobins, Abnormal; C030448:hemoglobin Bart's